«

»

Whichever Way ‘Repeal and Replace’ Blows, Pharma Is Due For Windfall

The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices, experts say. The...

Read the full post at Health and Science
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive